Organization Profile

You just read:

Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Parkinson's Disease (PD) Patients Whose Symptoms are Uncontrolled With Oral Medication

News provided by

Britannia Pharmaceuticals Ltd.

Aug 03, 2018, 07:04 ET